Cargando…
Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers
Lung cancer is a complex thoracic malignancy developing consequential to aberrations in a myriad of molecular and biomolecular signaling pathways. It is one of the most lethal forms of cancers accounting to almost 1.8 million new annual incidences, bearing overall mortality to incidence ratio of 0.8...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196938/ https://www.ncbi.nlm.nih.gov/pubmed/34138386 http://dx.doi.org/10.1007/s40820-021-00630-6 |